Form D · Biotechnology

CAPPELLA INC

Westford, MA · CIK 0001392088

Offering snapshot reported Feb 18, 2011 · SEC filing

Reported sold
$7.11M
Offering amount: $7.11M
Investors reported
14
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Feb 4, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 18, 2011Initial$7,111,612No comparison14SEC filing
Jul 6, 2010Initial$3,690,900No comparison8SEC filing
Jul 22, 2009Amendment$17,340,028-$460,161vs Jun 19, 200914SEC filing
Jun 19, 2009Initial$17,800,189No comparison13SEC filing
Mar 1, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-155590

Source: Form D, filed Feb 18, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eamonn Fahy Executive
Charlie Glass Director
Eamonn Hobbs Director
Dirk Kanngiesser Director
Masashi Kiyomine Director
Wolfgang Oster Director
Ena S. Prosser Director
Debbie Rennick Director
Arthur Rosenthal Director, Executive
Ascher Shmulewitz Director
Phil Watson Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
41 Magnolia Drive
Westford, MA, 01886